据病友心与心愿消息提供，美国ACT先进细胞技术公司CEO MR rabin将于9月13和14日在两个重要会议上提供公司正在进行的两个实验的最新消息。到时候网上有直播，有精通英文的网友可以第一时间知道实验进展。关于实验（胚胎干细胞治疗少年性黄斑变性和干性黄斑变性）上次的最新消息是7月份的，实验已经进行，患者耐受情况良好，但具体内容没有公布，期待下周的最新消息。
Mr. Rabin will provide updates on the company’s two ongoing human clinical trials using hESC-derived RPE cells to treat macular degeneration and other programs.
Mr. Rabin will present at the Rodman & Renshaw 13th Annual Healthcare Conference on Tuesday, Sept. 13, at 10:25 a.m. EDT, at the Waldorf Astoria.
A live audiocast will be available at the following link:
www.wsw.com/webcast/rrshq20/actc/. An archived version will also be available there and via ACT’s website at www.advancedcell.com. |
